A Clinical Study To Evaluate The Performances of A Pulsed Electric Field Ablation Through Percutaneous Approach for Patients With Early-Stage Lung Cancer or Lung Oligometastatic Tumor.
NCT: NCT07799194 · NOT_YET_RECRUITING
Brief Summary
The goal of this observational study is to evaluate the performances of a percutaneous Pulsed Electrical Field (PEF) ablation to treat patients with primary early-stage lung cancer (NSCLC) or lung oligometastatic Tumors who are unresectable or refusal surgery/Radiotherapy. The main questions the study aims to answer are: The safety and technical feasibility of the PEF ablation. The preliminary efficacy of the PEF ablation for target lesion in lung Patients who meet the inclusion/exclusion criteria will be given percutaneous PEF ablation to the target lesions under general anesthesia. Then follow-up to 12 months to monitor any progression by about 3 months interval. Target Subject： Patients with early-stage primary non-small cell lung cancer(NSCLC) or pulmonary oligometastatic tumors who are not surgical resectable or unsuitable for surgery/radiotherapy
Frequently Asked Questions
What is A Clinical Study To Evaluate The Performances of A Pulsed Electric Field Ablation Through Percutaneous Approach for Patients With Early-Stage Lung Cancer or Lung Oligometastatic Tumor.?
A Clinical Study To Evaluate The Performances of A Pulsed Electric Field Ablation Through Percutaneous Approach for Patients With Early-Stage Lung Cancer or Lung Oligometastatic Tumor. is a clinical trial registered under NCT07799194. Current status: NOT_YET_RECRUITING.
What is the status of NCT07799194?
The current status of NCT07799194 (A Clinical Study To Evaluate The Performances of A Pulsed Electric Field Ablation Through Percutaneous Approach for Patients With Early-Stage Lung Cancer or Lung Oligometastatic Tumor.) is: NOT_YET_RECRUITING.
When did A Clinical Study To Evaluate The Performances of A Pulsed Electric Field Ablation Through Percutaneous Approach for Patients With Early-Stage Lung Cancer or Lung Oligometastatic Tumor. start?
A Clinical Study To Evaluate The Performances of A Pulsed Electric Field Ablation Through Percutaneous Approach for Patients With Early-Stage Lung Cancer or Lung Oligometastatic Tumor. started on 2026-09.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.